publication date: Oct. 20, 2016
NCI CTEP-Approved Trials for the Month of October
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month. For further information, contact the principal investigator listed.
Phase I 9950
A phaseI Study of VX-970 in Combination with Cisplatin and XRT in Patients with Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma
(HNSCC; SDC 10060121)
JHU Sidney Kimmel Comprehensive
Cancer Center LAO
Owonikoko, Taofeek Kunle
Phase II NRG-GY008
A phaseII Evaluation of Copanlisib (BAY 80-6946) (IND #130822), a Selective Inhibitor of PI3KCA, in Patients with Persistent or Recurrent Endometrial Carcinoma Harboring PIK3CA Hotspot Mutations
Santin, Alessandro D.
Phase II A011502
A Randomized phaseIII Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer
The ABC Trial Alliance for Clinical Trials in Oncology Chen, Wendy Yvonne
Phase Other AOST16B1-Q
An Integrated Clinical and Genomic Analysis of Treatment Failure in Pediatric Osteosarcoma
Children’s Oncology Group
To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us
and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.